• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Organisation › Details

High-Tech Gründerfonds (HTGF) (Group)

High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven start-ups. With EUR 892.5 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge 500 start-ups since 2005. Driven by their expertise, entrepreneurial spirit and passion, its team of experienced investment managers and start-up experts help guide the development of young companies. HTGF’s focus is on high-tech start-ups in a range of sectors, including software, hardware and life sciences / chemistry. This group also includes a number of success stories, such as Mister Spex, Rigontec, 6Wunderkinder, Next Kraftwerke and Cumulocity, as well as Juniqe, an online shop for art enthusiasts. To date, external investors have injected over EUR 1.9 billion into the HTGF portfolio via about 1,400 follow-on financing rounds. *

 

	Start	2005-09-01 start
	Today	High-Tech Gründerfonds Management GmbH
	Industry	venture capital
	Industry 2	LIFE SCIENCES
	Person	Brandkamp, Michael (High-Tech Gründerfonds 201112 Managing Director)
	Region	Bonn
	Country	Germany
	Street	2 Schlegelstr.
	City	53113 Bonn
	Tel	+49-228-82300-100
		Address record changed: 2019-01-22
Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	573,500,000 (capital under management 2013-05-15)
		* Document for �About Section�: High-Tech Gründerfonds Management GmbH. (1/16/19). "Press Release: Series-A Investment for Munich-based Medical Technology Startup Mecuris".
		Record changed: 2019-05-01

Advertisement

More documents for High-Tech Gründerfonds (HTGF) (Group)

• [1] High-Tech Gründerfonds Management GmbH. (8/8/19). "Press Release: Successful Exit for High-Tech Gründerfonds (HTGF) – HTGF sells Its Cytena Shares to Cellink in a Trade Sale"....
• [2] High-Tech Gründerfonds Management GmbH. (7/3/19). "Press Release: “First-in-Class“ mRNA-therapeutics for Vascular Diseases – Pantherna Therapeutics Receives 7-digit Investment"....
• [3] High-Tech Gründerfonds Management GmbH. (5/15/19). "Press Release: Navan Closes Seed Funding Round – Investors include Amgen Ventures, HTGF and Hemi Ventures"....
• [4] High-Tech Gründerfonds Management GmbH. (5/7/19). "Press Release: Drug Discovery Technology Start-up DyNAbind Secures Seed Financing"....
• [5] High-Tech Gründerfonds Management GmbH. (5/2/19). "Press Release: miRdetect Receives Seed Financing – Consortium Invests Seven-Digit Amount in Serum Marker for Testicular Cancer Detection"....
• [6] Cytena GmbH. (3/26/19). "Press Release: EUR 3 Million in Series A for the Growth and Development of Cytena GmbH"....
• [7] High-Tech Gründerfonds Management GmbH. (2/14/19). "Press Release: Plasmion’ SICRIT Sensor Technology Convinces Investors"....
• [8] High-Tech Gründerfonds Management GmbH. (1/16/19). "Press Release: Series-A Investment for Munich-based Medical Technology Startup Mecuris"....
• [9] Atriva Therapeutics GmbH. (1/3/19). "Press Release: Atriva Therapeutics Announces First Closing of Series A Financing Round". Tübingen....
• [10] High-Tech Gründerfonds Management GmbH. (12/18/18). "Press Release: High-Tech Gründerfonds and Think.Health Ventures together with Business Angels Invest 3.3 Million Euros in a Series A for the Growth of PreOmics in Martinsried, Germany"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.